BRIUMVI Trademark

Trademark Overview


On Tuesday, June 8, 2021, a trademark application was filed for BRIUMVI with the United States Patent and Trademark Office. The USPTO has given the BRIUMVI trademark a serial number of 90760688. The federal status of this trademark filing is REGISTERED as of Tuesday, April 11, 2023. This trademark is owned by TG Therapeutics, Inc.. The BRIUMVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of multiple sclerosis
briumvi

General Information


Serial Number90760688
Word MarkBRIUMVI
Filing DateTuesday, June 8, 2021
Status700 - REGISTERED
Status DateTuesday, April 11, 2023
Registration Number7026905
Registration DateTuesday, April 11, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of multiple sclerosis
Translation of Words in MarkThe wording BRIUMVI has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 28, 2021
Primary Code005
First Use Anywhere DateTuesday, January 24, 2023
First Use In Commerce DateTuesday, January 24, 2023

Trademark Owner History


Party NameTG Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Party NameTG Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Party NameTG Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events


Event DateEvent Description
Tuesday, April 11, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 11, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 7, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 6, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 3, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 8, 2023USE AMENDMENT FILED
Monday, February 27, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 8, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, November 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, November 27, 2022SOU EXTENSION 1 GRANTED
Sunday, November 27, 2022SOU EXTENSION 1 FILED
Sunday, November 27, 2022TEAS EXTENSION RECEIVED
Tuesday, May 31, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 25, 2022ASSIGNED TO EXAMINER
Monday, October 18, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, October 18, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, August 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 11, 2021NEW APPLICATION ENTERED